Hongyan Guo

This inventor holds 28 USPTO granted patents and 16 published patent applications, plus 1 CIPO patent and 16 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Gilead Sciences, Inc., Gilead Pharmasset LLC, Korea Research Institute of Chemical Technology. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hongyan Guo. Retrieved from https://idiyas.com/inventor/hongyan-guo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 28 (Patent Applications = 16)

% Patents Active = 85.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 16 (Patent Applications = 22)

Average Co-Inventor Count = 11.8

ph-index = 8

Forward Citations = 235(Granted Patents)

Location History:

Foster City, CA (US) (2009 - 2012)
San Mateo, CA (US) (2011 - 2024)

Company Filing History:

17 out of 946

Gilead Sciences, Inc.

patents

4 out of 81

Gilead Pharmasset LLC

patents

3 out of 655

Korea Research Institute of Chemical Technology

patents

4. 2 out of 4

Lilac Therapeutics, Inc.

patents

5. 2 out of 245

Novartis Vaccines & Diagnostics, Gmbh

patents

Years Active: 2009-2025

Loading Chart...

Areas of Expertise:

Bridged Tricyclic Compounds

Pyridotriazine Compounds

Glycolate Oxidase Inhibitors

Thienopyrimidine Derivatives

ACC Inhibitors

Antiviral Compounds

HIV Reverse Transcriptase Inhibitors

Naphthalene Acetic Acid

Therapeutic Compounds

Pyrimidine Derivatives

Indole Derivatives

Benzimidazole Derivatives

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12421235 - Bridged tricyclic carbamoylpyridone compounds and uses thereof (2025-09-23),

2. 12227520 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use (2025-02-18),

3. 12187734 - Substituted pyridotriazine compounds and uses thereof (2025-01-07),

4. 12168002 - Heterocyclic carboxylate compounds as glycolate oxidase inhibitors (2024-12-17),

5. 11897892 - Substituted pyridotriazine compounds and uses thereof (2024-02-13),

6. 11806335 - Heterocyclic carboxylate compounds as glycolate oxidase inhibitors (2023-11-07),

7. 11613546 - Substituted pyridotriazine compounds and uses thereof (2023-03-28),

8. 11548902 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use (2023-01-10),

9. 11352371 - Thienopyrimidine derivatives as ACC inhibitors and uses thereof (2022-06-07),

10. 11084832 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use (2021-08-10),

11. 10800772 - Therapeutic compounds (2020-10-13),

12. 9981955 - Antiviral compounds (2018-05-29),

13. 9511056 - Antiviral compounds (2016-12-06),

14. 9296758 - 2-quinolinyl-acetic acid derivatives as HIV antiviral compounds (2016-03-29),

15. 9284323 - Naphthalene acetic acid derivatives against HIV infection (2016-03-15),

Title: The Inventor Spotlight: Hongyan Guo

Introduction:

Hongyan Guo, a prolific inventor based in San Mateo, CA (US), has left an indelible mark on the field of pharmaceuticals with his groundbreaking work and innovative patents.

Latest Patents:

1. Substituted pyridotriazine compounds and uses thereof: Guo's patent showcases tricyclic compounds that are vital in treating or preventing human immunodeficiency virus (HIV) infection.

2. Heterocyclic carboxylate compounds as glycolate oxidase inhibitors: This patent focuses on modulators of human glycolate oxidase enzyme, demonstrating Guo's versatile expertise.

Career Highlights:

With an impressive total of 24 patents to his name, Guo has made significant contributions at notable companies such as Gilead Sciences, Inc. and Gilead Pharmasset LLC. His dedication to research and development in the pharmaceutical industry is truly commendable.

Collaborations:

Throughout his career, Guo has collaborated with esteemed colleagues, including Michael L. Mitchell and Lianhong Xu, further emphasizing his collaborative spirit and ability to work effectively within multidisciplinary teams.

Conclusion:

In conclusion, Hongyan Guo's relentless pursuit of innovation and his profound impact on the field of pharmaceuticals underscore his status as a pioneering inventor. His patents continue to inspire advancements in the treatment of various medical conditions, leaving a lasting legacy in the realm of scientific discovery.

Profile summary based on public USPTO records.